ASCO in ActionASCO in Action regularly provides the latest news and analysis related to cancer policy news; see the following online articles. These updates provide snapshots of ASCO’s ongoing advocacy efforts, as well as opportunities for ASCO members and guests to take action on critical issues affecting the cancer community.

To sign up for advocacy alerts, log in to with your ASCO member or guest account, and visit the subscription center available under your account profile.

Tune in to ASCO's new ASCO in Action podcast series, providing analysis and commentary on cancer policy and practice issues, available through iTunes or Google Play.

Showing results for Cancer Research

August 16, 2018

Citizens around the country have an open invitation to host their own events in their communities with support and resources offered by the Biden Cancer Initiative in conjunction with the National Biden Cancer Summit to be held on September 21 in Washington, D.C. 

July 27, 2018

On July 25, the U.S. House Energy and Commerce Committee held a hearing during which Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, Director of the National Cancer Institute (NCI) Norman Sharpless, MD, and Director of National Institutes of Health Francis Collins, MD, PhD, provided updates on how their respective agencies have been implementing the 21st Century Cures legislation.

July 5, 2018

ASCO and the European Society for Medical Oncology (ESMO), are calling on leaders and health ministers of the 193 United Nations (UN) member countries to reduce the burden of all non-communicable diseases (NCDs), including cancer. The two organizations issued a joint statement in advance of the third High-level Meeting of the United Nations (UN) General Assembly on the Prevention and Control of NCDs, taking place on September 27, 2018, in New York.

June 26, 2018

In the latest ASCO in Action Podcast, Dr. Edward Kim, Chair of the Department of Solid Tumor Oncology at the Levine Cancer Institute, joined ASCO CEO Dr. Clifford A. Hudis to discuss eligibility criteria for cancer clinical trials.

June 20, 2018

The Department of Health and Human Services (HHS) has announced further delay for implementation of the updated Common Rule until January 2, 2019.

June 19, 2018

The Journal of Oncology Practice (JOP) launched a new care delivery blog, JOP DAiS (Discussion & Analysis in Short), to serve as a forum for commentary and analysis on issues affecting the mechanisms of oncology care delivery. This new platform will be a way to collaborate, debate, and discuss many of the topics JOP addresses in its publication including health services research, business and socioeconomics, ethics, and health policy.

June 18, 2018

A new review article in the Journal of Oncology Practice reexamines the roles of a principal investigator in the current environment of rapid drug discovery and development. The review outlines the increasing responsibilities of a principal investigator, the important role they play in compliance, and how those in the field can prepare to become a successful principal investigator.

June 5, 2018

On June 6, 2018, the One Voice Against Cancer Coalition (OVAC) will hold an “Online Day of Action” to advocate for increased funding for the National Institutes of Health (NIH) and the National Cancer Institute (NCI). 

May 30, 2018

Researchers can access a wide array of ASCO data through the society’s Center for Research and Analytics (CENTRA). A detailed list of the data, along with samples of each dataset, can be found on CENTRA’s updated Data Library page.

May 23, 2018

The U.S. House of Representatives passed the Childhood Cancer Survivorship, Treatment, Access, and Research (STAR) Act (H.R. 820/S. 292), which will help improve care for the nearly 16,000 children diagnosed with cancer in the United States every year.

May 18, 2018

On May 17, the Senate Appropriations Committee held a hearing to discuss the budget request for the National Institutes of Health (NIH) for Fiscal Year (FY) 2019. NIH Director Francis Collins, MD, PhD, and National Cancer Institute (NCI) Director Ned Sharpless, MD, both gave testimony at the hearing, where Dr. Sharpless underscored the need for adequate funding to strengthen the cancer research infrastructure.

May 16, 2018

The agenda has been set for the June 22 ASCO/Food and Drug Administration (FDA) “Core Outcome Assessments in Cancer Clinical Trials” workshop.

May 9, 2018

This ASCO in Action Brief is designed to help ASCO members gain a clearer understanding of the impact of state and federal right-to-try (RTT) legislation in the United States on oncology patients and practices.

May 3, 2018

ASCO’s Policy Issue Briefs provide succinct overviews and relevant data on major policy issues impacting patients with cancer and the physicians who care for them. These briefs are designed to be especially helpful for journalists, offering background information on key issues across health policy today. 

May 2, 2018

Register now to join research colleagues from across the U.S. at the ASCO Research Community Forum Annual Meeting. The meeting offers physician researchers and research staff, from a variety of types of research programs, a unique platform to collaborate and develop solutions to common challenges with conducting oncology clinical trials.